Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Adeno-associated viral vector serotype 8 containing the human alpha-galactosidase A gene

EU orphan designation number: EU/3/17/1849   
Active ingredient: Adeno-associated viral vector serotype 8 containing the human alpha-galactosidase A gene
Indication: Treatment of Fabry disease
Sponsor: Freeline Therapeutics Ltd
Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts SG1 2FX, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2017 Orphan designation EMA/OD/277/16 (2017)1976 of 20/03/2017
13/07/2018 Change of name and/or address of sponsor